Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitel

Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge funds investors who own 33% of the company

Key Insights Given the large stake in the stock by institutions, Prelude Therapeutics' stock price might be vulnerable...

Related Keywords

Krishna Vaddi , Prelude Therapeutics Incorporated , Prelude Therapeutic , Prelude Therapeutics , Nstitutional Ownership , Institutional Investors , Hedge Funds , Shareholders ,